Cargando…
CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming
Increased expression of CD147 in pancreatic cancer has been proposed to play a critical role in cancer progression via CD147 chaperone function for lactate monocarboxylate transporters (MCTs). Here, we show for the first time that CD147 interacts with membrane transporters beyond MCTs and exhibits a...
Autores principales: | Kendrick, Agnieszka A., Schafer, Johnathon, Dzieciatkowska, Monika, Nemkov, Travis, D'Alessandro, Angelo, Neelakantan, Deepika, Ford, Heide L., Pearson, Chad G., Weekes, Colin D., Hansen, Kirk C., Eisenmesser, Elan Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341751/ https://www.ncbi.nlm.nih.gov/pubmed/28039486 http://dx.doi.org/10.18632/oncotarget.14272 |
Ejemplares similares
-
Human and Bacterial Toll-Interleukin Receptor Domains Exhibit Distinct Dynamic Features and Functions
por: Lee, Eunjeong, et al.
Publicado: (2022) -
CD147: an integral and potential molecule to abrogate hallmarks of cancer
por: Nyalali, Alphonce M. K., et al.
Publicado: (2023) -
SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
por: Fenizia, Claudio, et al.
Publicado: (2021) -
Cyclophilin–CD147 interactions: a new target for anti-inflammatory therapeutics
por: Yurchenko, V, et al.
Publicado: (2010) -
Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming
por: D'Alessandro, Angelo, et al.
Publicado: (2018)